Vitrafy Life Sciences Ltd. · ASX:VFY
Vitrafy Life Sciences — Shareholder Meeting (November 2025)
30 slides from Vitrafy Life Sciences's shareholder meeting presentation, Nov 20, 2025
Slide 1: 2025 Annual General Meeting Chair Address and Presentation
ASX ANNOUNCEMENT 20 November 2025 2025 Annual General Meeting Chair Address and Presentation Vitrafy Life Sciences Limited (ASX: VFY), (Vitrafy or Company) advises in accordance with ASX Listing Rule 3.13.3, a copy of the address by Chair, Sonia Petering and slides to be presented at today’s Annual
Slide 2: Chair's Address
Chair’s Address Good afternoon, As announced last month: • We welcomed Dr Leigh Farrell to the Board of Vitrafy. Leigh will seek election today. • Dr John McBain will not offer himself for re-election and will retire as a Non-Executive Director at the close of the meeting. On behalf of my fellow dir
Slide 3: Chair's Address: FY25 review
FY25 was a year of foundation building. Becoming an ASX-listed company introduced new governance disciplines and responsibilities which we have embraced. Our successful IPO in November 2024, with a listing valuation of $127.5 million and an offering almost 100% oversubscribed, was a significant mile
Slide 4: Chair's Address: FY26 outlook
Looking ahead to FY26, the Board (under the new leadership of Dr Leigh Farrell) and the management team under Brent remain focused on execution of strategy, guided by science and technology and supported by strong governance. We recognise the challenges inherent in bringing new technology to market,
Slide 5: Annual General Meeting November 2025
For personal use only Annual General Meeting 20 November 2025 Vitrafy Life Sciences Limited vitrafy.com 1
Slide 6: Vitrafy Board of Directors
Introduction Vitrafy Board For personal use only of Directors Sonia Petering Brent Owens Kate Munnings Non-Executive Chair Managing Director and Non-Executive Director (retiring at the conclusion of today’s AGM) CEO John McBain Vaughan Webber Leigh Farrell Non-Executive Director Non-Executive Direct
Slide 7: Format of Meeting
Format of Meeting Chair Address For personal use only CEO Presentation Incoming Chair Remarks Q&A / Voting Procedure Overview Formal Business of Meeting General Questions Demonstration 3
Slide 8: Chair Address – Review of FY2025
Chair Address – Review of FY2025 Fy2025 was a period of growth and execution across all phases of the business to support future commercialisation For personal use only Organisational U.S. Operations Listed on the ASX Transition Established Sonia Petering Non-Executive Chair • Funding secured for •
Slide 9: CEO Presentation – Priorities as at the IPO
CEO Presentation – Priorities as at the IPO Vitrafy was supported to invest in building a platform that would support global expansion. For personal use only 1 Market Development • Business and market development activities • North American expansion • Operational capacity buildout Investment A$10.9
Slide 10: CEO Presentation – Milestones of FY25
CEO Presentation – Milestones of FY25 FY2025 has seen For personal use only milestones and progress in all activities outlined to Market Development Technology Development Grow Operational Capacity investors at the IPO. • U.S. footprint expansion • Milestones achieved in • Commenced buildout of with
Slide 11: CEO Presentation – FY26 Annual Objectives
CEO Presentation – FY26 Annual Objectives For personal use only 1. Market Development 2. Products in Market 3. Organisational Capability Quality and Consistency 7
Slide 12: CEO Presentation – Operational Outlook
CEO Presentation – Operational Outlook Vitrafy remains steadfast in its commercialisation roadmap and plan it is executing on. For personal use only Long Term Medium Term • Setting new quality standards for cryopreserved materials Short Term • Supply chain integration. • Becoming the global leader i
Slide 13: CEO Presentation – A Note of Thanks
CEO Presentation – A Note of Thanks As at the AGM, Vitrafy is farewelling two Directors who have been instrumental in leading the Company through its early success. For personal use only Sonia Petering John McBain Non-Executive Chair Non-Executive Director (retiring at the conclusion of today’s AGM)
Slide 14: Incoming Chair Remarks
Incoming Chair Remarks Vitrafy welcomes Dr. Leigh Farrell as incoming Chair of the Board to support, guide, mentor and govern the Company through its next phase of growth. For personal use only Dr. Leigh Farrell 10
Slide 15: Incoming Chair Remarks
Incoming Chair Remarks Focussed on supporting the Company execute its commercialisation strategy rooted in experienced leadership and performance. For personal use only Immersion Strategic Alignment Execution Dr. Leigh Governance and structures Farrell Stakeholder engagement Strategic planning Non-E
Slide 16: CEO Demonstration – Guardion device
CEO Demonstration – Guardion device For personal use only Controlled & tailored cryopreservation Automated & Intelligence Continuous Throughput Brent Owens Managing Director and Rapid processing times <5 min CEO Low Power requirement Liquid Nitrogen Free Integration with LifeChain Controlled | Intel
Slide 17: Q&A / Voting Procedure Overview
For personal use only Q&A / Voting Procedure Overview 13
Slide 18: Formal Business of the Meeting
For personal use only Formal Business of the Meeting 14
Slide 19: Proxy Voting Summary
Proxy Voting Summary RESOLUTION FOR AGAINST OPEN1 For personal use only Resolution 1 75.48% 1.16% 23.36% Resolution 2 79.20% 1.54% 19.26% Resolution 3 82.82% 0.81% 16.37% Resolution 4 80.83% 0.91% 18.26% Resolution 5 81.03% 0.90% 18.07% Resolution 6 82.82% 0.81% 16.37% Resolution 7 74.35% 9.28% 16.3
Slide 20: Financial Statements and Reports
Financial Statements and Reports To receive and consider the Company’s Financial Statements, Directors’ Report and Auditor’s Report for the financial year ended 30 June 2025. For personal use only Further Information • Simon Martin, Chief Financial Officer of Vitrafy and Tim Jackman, Audit Partner f
Slide 21: Resolution – Adoption of Remuneration Report
Resolution 1 – Adoption of Remuneration Report To consider and, if thought fit, to pass the following resolution as a non-binding ordinary resolution: For personal use only “That, for the purpose of section 250R(2) of the Corporations Act and for all other purposes, approval is given for the adoptio
Slide 22: Resolution – Re-election of Vaughan Webber as a Director
Resolution 2 – Re-election of Vaughan Webber as a Director To consider and, if thought fit, pass the following resolution as an ordinary resolution: For personal use only "That, Vaughan Webber, a Director of the Company who retires in accordance with clause 64.1 of the Company’s Constitution and, be
Slide 23: Resolution – Election of Leigh Farrell as a Director
Resolution 3 – Election of Leigh Farrell as a Director To consider and, if thought fit, pass the following resolution as an ordinary resolution: For personal use only "That, Dr Leigh Farrell, who was appointed as an addition to the Board since the last Annual General Meeting of the Company and who r
Slide 24: Resolution – Adoption of the Company's Equity Incentive Plan
Resolution 4 – Adoption of the Company’s Equity Incentive Plan To consider and, if thought fit, pass the following resolution as an ordinary resolution: For personal use only “That for the purposes of Listing Rules 7.1 and 7.1A (Exception 13(b) of Listing Rule 7.2), and for all other purposes, Share
Slide 25: Resolution – Grant of Performance Rights to Brent Owens
Resolution 5 – Grant of Performance Rights to Managing Director and CEO, Brent Owens To consider and, if thought fit, pass the following resolution as an ordinary resolution: For personal use only “That, for the purposes of the purpose of Listing Rule 10.14, sections 200B and 200E of the Corporation
Slide 26: Resolution – Approval to vary terms of Options
Resolution 6 – Approval to vary terms of Options held by former Managing Director and CEO, Kate Munnings To consider and, if thought fit, pass the following resolution as an ordinary resolution: For personal use only “That for the purposes of Listing Rule 6.23.4 and for all other purposes, Sharehold
Slide 27: Resolution – Approval of 10% Placement Facility
Resolution 7 – Approval of 10% Placement Facility To consider and, if thought fit, pass the following resolution as a special resolution: For personal use only “That, pursuant to and in accordance with Listing Rule 7.1A and for all other purposes, Shareholders approve the issue of Equity Securities
Slide 28: General Questions
For personal use only General Questions 24
Slide 29: Voting Closure and End of Formal Business
For personal use only Voting Closure and End of Formal Business 25
Slide 30: Thank you
For personal use only Thank you Vitrafy Life Sciences Limited vitrafy.com Strictly Private & Confidential 26
Vitrafy Life Sciences — Shareholder Meeting (November 2025) on 6ix